[Federal Register: September 2, 1998 (Volume 63, Number 170)] [Notices] [Page 46796-46797] From the Federal Register Online via GPO Access [wais.access.gpo.gov] [DOCID:fr02se98-83] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention National Vaccine Advisory Committee, Subcommittee on Future Vaccines, Subcommittee on Immunization Coverage, and Subcommittee on Vaccine Safety: Meetings In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces the following Federal advisory committee meetings. Name: National Vaccine Advisory Committee (NVAC). [[Page 46797]] Times and Dates: 9 a.m.-2 p.m., September 28, 1998; 8 a.m.-12:30 p.m. September 29, 1998. Place: Hubert H. Humphrey Building, Room 800, 200 Independence Avenue, SW, Washington, DC 20201. Status: Open to the public, limited only by the space available. Notice: In the interest of security, the Department has instituted stringent procedures for entrance to the Hubert H. Humphrey Building by non-government employees. Thus, persons without a government identification card should plan to arrive at the building each by either between 8 and 8:30 a.m. or 12:30 and 1 p.m. so they can be escorted to the meeting. Entrance to the meeting at other times during the day cannot be assured. Purpose: This committee advises and makes recommendations to the Director of the National Vaccine Program on matters related to the Program responsibilities. Matters to be Discussed: Agenda items will include updates on the National Vaccine Program Office (NVPO) activities; a report from the Division of Vaccine Injury Compensation; a discussion on the impact of changes in Federal funding of vaccine programs, the Food and Drug Administration, National Immunization Program and Association of State and Territorial Health Officers; a report from the Assistant Secretary for Health and Surgeon General; a discussion on the current status of NIH efforts to develop a vaccine to prevent AIDS; a report from the task force on community preventive services; status of NVAC papers, strategies to sustain immunization coverage; a report fostering non-traditional sites for promoting adult immunization, and case studies of vaccine development; a discussion on the progress in influenza pandemic preparedness; potential utility of new influenza vaccines, blueprint strategy for tuberculosis vaccine development; reports from the Immunization Registries Workgroup, progress toward a strategic plan, Subcommittee on Future Vaccines, Subcommittee on Immunization Coverage and Subcommittee on Vaccine Safety; a discussion on future agenda items. Name: Subcommittee on Future Vaccines. Time and Date: 2 p.m.-5 p.m., September 28, 1998. Place: Hubert H. Humphrey Building, Room 703, 200 Independence Avenue, SW, Washington, DC 20201. Status: Open to the public, limited only by the space available. Purpose: This subcommittee develops policy options and guides national activities that lead to accelerated development, licensure, and the best use of new vaccines in the simplest possible immunization schedules. Matters to be Discussed: Agenda items will include discussions regarding ``Orphan Vaccines'' How can we expedite the development of certain vaccines? Follow-up of discussion on indemnification for phase 1 clinical trials. Name: Subcommittee on Immunization Coverage. Time and Date: 2 p.m.-5 p.m., September 28, 1998. Place: Hubert H. Humphrey Building, Room 800, 200 Independence Avenue, SW, Washington, DC 20201. Status: Open to the public, limited only by the space available. Purpose: This subcommittee will identify and propose solutions that provide a multifaceted and holistic approach to reducing barriers that result in low immunization coverage for children. Matters to be Discussed: Agenda items will include updates on the status of the Immunization Coverage paper, ``Strategies to Sustain Immunization Coverage'', adult immunization at non- traditional sites, and a discussion of adolescent frame work for immunization. Name: Subcommittee on Vaccine Safety. Time and Date: 2 p.m.-5 p.m., September 28, 1998. Place: Hubert H. Humphrey Building, Room 705A, 200 Independence Avenue, SW, Washington, DC 20201. Status: Open to the public, limited only by the space available. Purpose: This subcommittee reviews issues relevant to vaccine safety and adverse reactions to vaccines. Matters to be Discussed: Agenda items include a discussion on the review of the draft public health service vaccine safety action plan. Agenda items are subject to change as priorities dictate. Contact Person for More Information: Felecia D. Pearson, Committee Management Specialist, NVPO, CDC, 1600 Clifton Road, NE, M/S A-11, Atlanta, Georgia 30333, telephone 404/639-4450. Dated: August 27, 1998. Carolyn J. Russell, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention (CDC). [FR Doc. 98-23666 Filed 9-1-98; 8:45 am] BILLING CODE 4163-18-P